2023 Diagnostic Imaging Disease Nuclear Medicine 
AuntMinnie
MARCH 26, 2024
Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman.
Imaging Technology
OCTOBER 11, 2023
milla1cf Wed, 10/11/2023 - 13:08 October 11, 2023 — A new imaging agent, 68Ga-ABY-025 , can predict early metabolic response to human epidermal growth factor receptor 2 ( HER2 )-targeted treatment in HER2-positive metastatic breast cancer patients, according to new research published in the September issue of The Journal of Nuclear Medicine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
JUNE 20, 2024
Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman.
Imaging Technology
OCTOBER 13, 2023
Summers said LLM tools could be used to extract important information from other text-based radiology reports and medical records, and as a tool for identifying disease biomarkers. “My My lab has been focusing on extracting features from diagnostic images,” he said.
AuntMinnie
JULY 9, 2024
In an article posted on May 11, 2023, by the Global Coalition for Radiotherapy , he spoke about the commitment to deliver care despite the challenges. Attacking a children's hospital, where children are treated for cancer and other serious diseases, is not just a war crime; it is beyond the bounds of humanity.
Imaging Technology
JUNE 29, 2023
milla1cf Thu, 06/29/2023 - 21:10 June 29, 2023 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 Blue Earth Diagnostics received U.S.
Imaging Technology
APRIL 3, 2023
produced, non-uranium based Mo-99 for use in diagnostic imaging. These capabilities will help them develop and deliver products with the potential to improve care for even more patients with serious disease. “In In parallel with these initiatives, NorthStar’s imaging portfolio continues to advance,” Mr. Merrick further added.
Expert insights. Personalized for you.
122 
Let's personalize your content